
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Design and Implementation of Synthetic RNA Binders for the Inhibition of miR-21 Biogenesis
Chloé Maucort, Duc Duy Vo, Samy Aouad, et al.
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 6, pp. 899-906
Open Access | Times Cited: 29
Chloé Maucort, Duc Duy Vo, Samy Aouad, et al.
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 6, pp. 899-906
Open Access | Times Cited: 29
Showing 1-25 of 29 citing articles:
Targeting RNA structures with small molecules
Jessica L. Childs‐Disney, Xueyi Yang, Quentin M. R. Gibaut, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 10, pp. 736-762
Open Access | Times Cited: 353
Jessica L. Childs‐Disney, Xueyi Yang, Quentin M. R. Gibaut, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 10, pp. 736-762
Open Access | Times Cited: 353
Small molecule approaches to targeting RNA
Sandra Kovachka, Marc Panosetti, Benedetto Grimaldi, et al.
Nature Reviews Chemistry (2024) Vol. 8, Iss. 2, pp. 120-135
Open Access | Times Cited: 37
Sandra Kovachka, Marc Panosetti, Benedetto Grimaldi, et al.
Nature Reviews Chemistry (2024) Vol. 8, Iss. 2, pp. 120-135
Open Access | Times Cited: 37
MicroRNA-21's role in PTEN suppression and PI3K/AKT activation: Implications for cancer biology
Himmat Singh Chawra, Mohit Agarwal, Anurag Mishra, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155091-155091
Closed Access | Times Cited: 21
Himmat Singh Chawra, Mohit Agarwal, Anurag Mishra, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155091-155091
Closed Access | Times Cited: 21
Small-molecule RNA ligands: a patent review (2018-2024)
Elia Ravegnini, Andrea Trabocchi, Elena Lenci
Expert Opinion on Therapeutic Patents (2025)
Closed Access | Times Cited: 1
Elia Ravegnini, Andrea Trabocchi, Elena Lenci
Expert Opinion on Therapeutic Patents (2025)
Closed Access | Times Cited: 1
Targeting the epigenome to reinvigorate T cells for cancer immunotherapy
Dian Xiong, Lu Zhang, Zhi‐Jun Sun
Military Medical Research (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 21
Dian Xiong, Lu Zhang, Zhi‐Jun Sun
Military Medical Research (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 21
Targeting MicroRNAs with Small Molecules
Kisanet Tadesse, Raphael I. Benhamou
Non-Coding RNA (2024) Vol. 10, Iss. 2, pp. 17-17
Open Access | Times Cited: 7
Kisanet Tadesse, Raphael I. Benhamou
Non-Coding RNA (2024) Vol. 10, Iss. 2, pp. 17-17
Open Access | Times Cited: 7
Heterobifunctional small molecules to modulate RNA function
Sandra Kovachka, Yuquan Tong, Jessica L. Childs‐Disney, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 5, pp. 449-463
Closed Access | Times Cited: 6
Sandra Kovachka, Yuquan Tong, Jessica L. Childs‐Disney, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 5, pp. 449-463
Closed Access | Times Cited: 6
Accurate Physics-Based Prediction of Binding Affinities of RNA- and DNA-Targeting Ligands
Ara M. Abramyan, Anna Bochicchio, Chuanjie Wu, et al.
Journal of Chemical Information and Modeling (2025)
Closed Access
Ara M. Abramyan, Anna Bochicchio, Chuanjie Wu, et al.
Journal of Chemical Information and Modeling (2025)
Closed Access
Electrostatic Anchoring in RNA-Ligand Design─Dissecting the Effects of Positive Charges on Affinity, Selectivity, Binding Kinetics, and Thermodynamics
Laura Almena Rodriguez, Elisabeth Kallert, Jan-Åke Husmann, et al.
Journal of Medicinal Chemistry (2025)
Open Access
Laura Almena Rodriguez, Elisabeth Kallert, Jan-Åke Husmann, et al.
Journal of Medicinal Chemistry (2025)
Open Access
RNA-Based Molecular Applications as Tool Compounds in Diagnostic and Clinical Settings
Shivani Singh, K N Gupta, Sonakshi Mishra, et al.
(2025), pp. 175-206
Closed Access
Shivani Singh, K N Gupta, Sonakshi Mishra, et al.
(2025), pp. 175-206
Closed Access
Development of Comprehensive Screening and Assessment Assays for Small-Molecule Ligands of MALAT1 lncRNA
Mélanie Pernak, Claire Fleurisson, Cécile Delorme, et al.
ACS Chemical Biology (2025)
Closed Access
Mélanie Pernak, Claire Fleurisson, Cécile Delorme, et al.
ACS Chemical Biology (2025)
Closed Access
Protein-Based Virtual Screening Tools Applied for RNA–Ligand Docking Identify New Binders of the preQ1-Riboswitch
Elisabeth Kallert, Tim R. Fischer, Simon Schneider, et al.
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 17, pp. 4134-4148
Open Access | Times Cited: 17
Elisabeth Kallert, Tim R. Fischer, Simon Schneider, et al.
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 17, pp. 4134-4148
Open Access | Times Cited: 17
Small molecules targeting microRNAs: new opportunities and challenges in precision cancer therapy
Ancuța Jurj, Beatrice Fontana, Gabriele Varani, et al.
Trends in cancer (2024) Vol. 10, Iss. 9, pp. 809-824
Closed Access | Times Cited: 3
Ancuța Jurj, Beatrice Fontana, Gabriele Varani, et al.
Trends in cancer (2024) Vol. 10, Iss. 9, pp. 809-824
Closed Access | Times Cited: 3
Design, Synthesis, and Evaluation of Neomycin‐Imidazole Conjugates for RNA Cleavage
Céline Martin, Maurinne Bonnet, Nadia Patino, et al.
ChemPlusChem (2022) Vol. 87, Iss. 11
Open Access | Times Cited: 16
Céline Martin, Maurinne Bonnet, Nadia Patino, et al.
ChemPlusChem (2022) Vol. 87, Iss. 11
Open Access | Times Cited: 16
De‐Novo Design of pre‐miR‐21 Maturation Inhibitors: Synthesis and Activity Assessment
Iryna Shcheholeva, Daniel Fernández‐Remacha, Roger Estrada‐Tejedor, et al.
Chemistry - A European Journal (2023) Vol. 29, Iss. 40
Open Access | Times Cited: 7
Iryna Shcheholeva, Daniel Fernández‐Remacha, Roger Estrada‐Tejedor, et al.
Chemistry - A European Journal (2023) Vol. 29, Iss. 40
Open Access | Times Cited: 7
Synthesis of Bleomycin-Inspired RNA Ligands Targeting the Biogenesis of Oncogenic miRNAs
Chloé Maucort, Maurinne Bonnet, Jean‐Claude Ortuno, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 15, pp. 10639-10657
Open Access | Times Cited: 7
Chloé Maucort, Maurinne Bonnet, Jean‐Claude Ortuno, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 15, pp. 10639-10657
Open Access | Times Cited: 7
Transcriptome-Wide, Unbiased Profiling of Ribonuclease Targeting Chimeras
Yuquan Tong, Xiaoxuan Su, Warren B. Rouse, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 31, pp. 21525-21534
Closed Access | Times Cited: 2
Yuquan Tong, Xiaoxuan Su, Warren B. Rouse, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 31, pp. 21525-21534
Closed Access | Times Cited: 2
Targeting RNA with small molecules, from RNA structures to precision medicines: IUPHAR review: 40
Yuquan Tong, Jessica L. Childs‐Disney, Matthew D. Disney
British Journal of Pharmacology (2024) Vol. 181, Iss. 21, pp. 4152-4173
Closed Access | Times Cited: 2
Yuquan Tong, Jessica L. Childs‐Disney, Matthew D. Disney
British Journal of Pharmacology (2024) Vol. 181, Iss. 21, pp. 4152-4173
Closed Access | Times Cited: 2
DNA‐Encoded Libraries and Their Application to RNA
Xueyi Yang, Jessica L. Childs‐Disney, M. Paegel, et al.
Israel Journal of Chemistry (2023) Vol. 63, Iss. 10-11
Open Access | Times Cited: 6
Xueyi Yang, Jessica L. Childs‐Disney, M. Paegel, et al.
Israel Journal of Chemistry (2023) Vol. 63, Iss. 10-11
Open Access | Times Cited: 6
Potential of miRNA as Imaging Targets for PET
Simon H. Zientek, Stephen Thompson, Franklin I. Aigbirhio, et al.
Helvetica Chimica Acta (2024) Vol. 107, Iss. 8
Open Access | Times Cited: 1
Simon H. Zientek, Stephen Thompson, Franklin I. Aigbirhio, et al.
Helvetica Chimica Acta (2024) Vol. 107, Iss. 8
Open Access | Times Cited: 1
Development of 2-deoxystreptamine–nucleobase conjugates for the inhibition of oncogenic miRNA production
Thi Phuong Anh Tran, Sylvain Poulet, Mélanie Pernak, et al.
RSC Medicinal Chemistry (2021) Vol. 13, Iss. 3, pp. 311-319
Open Access | Times Cited: 6
Thi Phuong Anh Tran, Sylvain Poulet, Mélanie Pernak, et al.
RSC Medicinal Chemistry (2021) Vol. 13, Iss. 3, pp. 311-319
Open Access | Times Cited: 6
The copious capabilities of non-coding RNAs in cancer regulation, diagnosis and treatment
Aideen McCabe, Oza Zaheed, Magdalina Derlipanska, et al.
Cancer Treatment and Research Communications (2023) Vol. 37, pp. 100768-100768
Open Access | Times Cited: 2
Aideen McCabe, Oza Zaheed, Magdalina Derlipanska, et al.
Cancer Treatment and Research Communications (2023) Vol. 37, pp. 100768-100768
Open Access | Times Cited: 2
NMR 1H,19F-based screening of the four stem-looped structure 5_SL1–SL4 located in the 5′-untranslated region of SARS-CoV 2 RNA
Daniel Hymon, Jason Martins, Christian Richter, et al.
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 165-177
Open Access | Times Cited: 2
Daniel Hymon, Jason Martins, Christian Richter, et al.
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 165-177
Open Access | Times Cited: 2
Maria Duca
Methods and principles in medicinal chemistry (2024), pp. 119-150
Closed Access
Therapeutic targeting non-coding RNAs
Roslyn M. Ray, Andreea Daniela Lazăr, Liliana Roxana Balahura, et al.
Elsevier eBooks (2023), pp. 349-417
Closed Access | Times Cited: 1
Roslyn M. Ray, Andreea Daniela Lazăr, Liliana Roxana Balahura, et al.
Elsevier eBooks (2023), pp. 349-417
Closed Access | Times Cited: 1